focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.675
Bid: 1.65
Ask: 1.70
Change: 0.025 (1.52%)
Spread: 0.05 (3.03%)
Open: 1.65
High: 1.95
Low: 1.65
Prev. Close: 1.65
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: 88 Energy surges; Petro Matad plans fundraise

Fri, 03rd Feb 2023 10:26

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.

----------

AIM - WINNERS

----------

88 Energy Ltd, up 17% at 0.69 pence, 12-month range 0.40p-2.82p. The Alaska-focused oil explorer on recovers after a 9.1% share price fall on Thursday. On Thursday, it said it plans to raise up to AUD12.0 million, about GBP6.8 million, through a placing. The company said it also has the ability to accept over-subscriptions to increase the total amount raised to up to AUD15.0 million. The shares are priced at AUD0.0095, which represents a 21% discount to the shares closing priced on the Australian Securities Exchange on Wednesday. The company says the proceeds will be used to fund the planned Hickory-1 well at Project Phoenix, payment for the new Project Leonis acreage, and finance potential portfolio expansion.

----------

Genedrive PLC, up 13% at 24.32p, 12-month range 8.00p-42.00p. The Manchester-based molecular diagnostics company continues to surge after strong start to 2023. Since the start of the year, the company's shares are up 99%, over the past 12-months stock is up 13%.

----------

AIM - LOSERS

----------

Petro Matad Ltd, down 33% at 2.74p, 12-month range 1.60p-5.60p. On Thursday, the petroleum exploration company focused on Mongolia said it plans to raise GBP500,000 through a retail offer by way of an accelerated bookbuild process at an issue price of 2.5 pence per retail offer share. Petro noted that the retail offer is conditional on the capital-raising shares being admitted to trading on AIM.

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
31 Aug 2021 21:35

TRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory live

TRADING UPDATES: Jet2 in bumper Airbus order; Strix China factory live

Read more
31 Aug 2021 12:05

Genedrive to seek CE mark clearance for MT-RNR1 assay

(Sharecast News) - Molecular diagnostics company Genedrive said on Tuesday that it will soon launch its MT-RNR1 assay, used for the detection of antibiotic-induced hearing loss in newborns.

Read more
1 Jul 2021 19:26

TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free

TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free

Read more
1 Jul 2021 09:52

Genedrive makes progress with Covid-19 test development

(Sharecast News) - Molecular diagnostics company Genedrive updated the market on the development of its 'COV19-ID Kit', a rapid point-of-care molecular test for SARS-CoV-2 detection designed for its 'Genedrive instrument', on Thursday.

Read more
25 Jun 2021 14:39

IN BRIEF: Genedrive receives Indian import license for Covid test kit

IN BRIEF: Genedrive receives Indian import license for Covid test kit

Read more
30 Apr 2021 13:16

Genedrive Covid-19 test formally approved in India

(Sharecast News) - Molecular diagnostics company Genedrive announced on Friday that the 'Genedrive 96' SARS-CoV-2 kit had been formally approved by the Indian Council of Medical Research (ICMR).

Read more
30 Apr 2021 10:51

Genedrive shares surge after Covid test approved by Indian regulator

Genedrive shares surge after Covid test approved by Indian regulator

Read more
30 Apr 2021 10:40

AIM WINNERS & LOSERS: Hurricane Energy warns of "significant dilution"

AIM WINNERS & LOSERS: Hurricane Energy warns of "significant dilution"

Read more
23 Apr 2021 10:02

Genedrive says study shows kit is effective at diagnosing Hepatitis C

Genedrive says study shows kit is effective at diagnosing Hepatitis C

Read more
19 Apr 2021 14:10

UPDATE: Yourgene wins further national framework contract award

UPDATE: Yourgene wins further national framework contract award

Read more
19 Apr 2021 12:46

IN BRIEF: Genedrive included in Public Health England framework

IN BRIEF: Genedrive included in Public Health England framework

Read more
19 Apr 2021 12:07

Genedrive appointed to PHE microbiology supply framework

(Sharecast News) - Molecular diagnostics company Genedrive has been successful with its tender to Public Health England (PHE) under Lot 1 of the National Microbiology Framework for diagnostic goods and services, it announced on Monday.

Read more
19 Apr 2021 11:44

Yourgene wins national contract award for Covid-19 testing services

Yourgene wins national contract award for Covid-19 testing services

Read more
19 Apr 2021 11:32

AIM WINNERS & LOSERS: Pantheon falls after Alaska drilling results

AIM WINNERS & LOSERS: Pantheon falls after Alaska drilling results

Read more
25 Mar 2021 14:49

TRADING UPDATES: Safestyle in strong start to 2021; Tandem ups payout

TRADING UPDATES: Safestyle in strong start to 2021; Tandem ups payout

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.